PH16771A - Synergistic mixtures of cepsulodin sodium and an aminoglycoside - Google Patents

Synergistic mixtures of cepsulodin sodium and an aminoglycoside

Info

Publication number
PH16771A
PH16771A PH22386A PH22386A PH16771A PH 16771 A PH16771 A PH 16771A PH 22386 A PH22386 A PH 22386A PH 22386 A PH22386 A PH 22386A PH 16771 A PH16771 A PH 16771A
Authority
PH
Philippines
Prior art keywords
cepsulodin
aminoglycoside
sodium
synergistic mixtures
synergistic
Prior art date
Application number
PH22386A
Other languages
English (en)
Inventor
Friedrich Kradolfer
Otokar Zak
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH16771A publication Critical patent/PH16771A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH22386A 1978-04-19 1979-04-06 Synergistic mixtures of cepsulodin sodium and an aminoglycoside PH16771A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH419478 1978-04-19

Publications (1)

Publication Number Publication Date
PH16771A true PH16771A (en) 1984-02-22

Family

ID=4271539

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22386A PH16771A (en) 1978-04-19 1979-04-06 Synergistic mixtures of cepsulodin sodium and an aminoglycoside

Country Status (11)

Country Link
US (1) US4263280A (es)
EP (1) EP0004925B1 (es)
JP (1) JPS54145221A (es)
AU (1) AU523468B2 (es)
CA (1) CA1134269A (es)
DE (1) DE2962171D1 (es)
ES (1) ES479636A1 (es)
IL (1) IL57086A (es)
NZ (1) NZ190218A (es)
PH (1) PH16771A (es)
ZA (1) ZA791822B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58198416A (ja) * 1982-05-15 1983-11-18 Ota Seiyaku Kk セフアレキシンドライシロツプ剤の製造法
EP0134302B1 (en) * 1983-09-15 1987-06-16 Bristol-Myers Company Pharmaceutical compositions for treating resistant bacteria including anaerobes
JPS6143116A (ja) * 1984-08-03 1986-03-01 Shionogi & Co Ltd 細菌性感染症の治療および治療薬
AT392903B (de) * 1987-10-08 1991-07-10 Hoechst Ag Pharmazeutische zubereitung enthaltend ein cephalosporin und ein penemantibiotikum
HUT57219A (en) * 1989-09-04 1991-11-28 Beecham Group Plc Process for producing new beta-lactame compounds
US6063590A (en) * 1991-11-18 2000-05-16 The United States Of America As Represented By The Administrator Of The U.S. Environmental Protection Agency Membrane filter agar medium containing two enzyme substrates used for the simultaneous detection of total coliforms and E. coli.
US6306621B1 (en) * 1991-11-18 2001-10-23 The United States Of America As Represented By The Administrator Of The U.S. Environmental Protection Agency Membrane filter agar medium for simultaneous detection of total coliforms and E. coli
MX2007007235A (es) * 2004-12-17 2007-10-19 Venus Remedies Ltd Combinacion de antibioticos para proporcionar una solucion total al tratamiento de infecciones.
US20060222716A1 (en) * 2005-04-01 2006-10-05 Joseph Schwarz Colloidal solid lipid vehicle for pharmaceutical use
CN102367258A (zh) * 2010-10-26 2012-03-07 海南美好西林生物制药有限公司 一种美洛西林钠的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1310642A (en) * 1970-11-09 1973-03-21 Pfizer Alpha-sulfo-and alpha-sulfoalkylacylcephalosporins
BE786271A (fr) * 1971-07-17 1973-01-15 Takeda Chemical Industries Ltd Cephalosporines

Also Published As

Publication number Publication date
JPS54145221A (en) 1979-11-13
EP0004925B1 (de) 1982-02-24
ES479636A1 (es) 1980-01-16
EP0004925A1 (de) 1979-10-31
IL57086A (en) 1982-09-30
CA1134269A (en) 1982-10-26
DE2962171D1 (en) 1982-03-25
AU523468B2 (en) 1982-07-29
IL57086A0 (en) 1979-07-25
NZ190218A (en) 1982-03-23
US4263280A (en) 1981-04-21
ZA791822B (en) 1980-04-30
AU4606779A (en) 1979-10-25

Similar Documents

Publication Publication Date Title
GB2046737B (en) Antihypercholesteraemic agent monacolin k and its preparation
EG13903A (en) Sodium sesqwiglyphosate
JPS5551642A (en) Wiperrblade and its preparation
JPS5797083A (en) Accerelation of matter
JPS5538394A (en) Imidazolylvinylether and its application
IL57086A (en) Synergistic mixtures of cefsulodin sodium and a second antibiotic
JPS5329915A (en) Prepararation of sodium amoxycillin and solution for it
JPS5535089A (en) Penamm1*11dioxide and its composition
GB2020648B (en) Dervitatives of pyrrolidine and piperidinecarboxaldehyde
IL61039A (en) Preparation of 1-azolyl-1-phenoxy-alkan-2-ones and 1-azolyl-1-halo-alkan-2-ones used therefor
JPS55111500A (en) Sodium alumoglucoheptonate and its manufacture
GB2023599B (en) Thienopyridone and furopyridone derivatives
GB2016477B (en) -glycoprotein and isolation thereof
JPS5639067A (en) Pyrrolidineedione derivatives and mildewcidal composition containing them
JPS52142059A (en) Phenylisoindole derivative* its preparation and agent containing same
ZA794940B (en) Imidazolylethoxy derivatives of pyridin-5-methanols and quinoline-3-methanols
IL61626A0 (en) 6-pyridinyl-pyridazine derivatives and pharmalceutical compositions containing them
JPS5610473A (en) Structure of printingghammer
JPS5636096A (en) Port structure of operation member in shielding box
JPS54110334A (en) Novel compounded anodyne and antiiinflammatory agent
JPS5524191A (en) Phenoxybutane and its derivatives
JPS5642976A (en) Groundinggresistance reducing agent
JPS55141246A (en) Odor reducing agent and its preparation
JPS5414382A (en) Reducing and decoloring agent
JPS55102577A (en) Pyridinesulfonamides and its application